Acetaminophen-induced hepatotoxicity: A comprehensive update

Journal of Clinical and Translational Hepatology

Volumn 4, Issue 2, 2016, Pages 131-142

  Yoon, Eric ^a   Babar, Arooj ^a   Choudhary, Moaz ^a   Kutner, Matthew ^a   Pyrsopoulos, Nikolaos ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Acetaminophen toxicity; Acute liver failure (ALF); APAP; Hepatotoxicity; Paracetamol

Indexed keywords

EID: 84995456577     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2015.00052     Document Type: Review

References (77)

1. Bunchorntavakul C, Reddy KR. Acetaminophen-related Hepatotoxicity. Clin Liver Dis 2013;17:587–607. doi: 10.1016/j.cld.2013.07.005.
2. Herndon CM, Dankenbring DM. Patient perception and knowledge of acetaminophen in a large family medicine service. J Pain Palliat Care Pharmacother 2014;28:109–116. doi: 10.3109/15360288.2014.908993.
3. Clark R, Fisher JE, Sketris IS, Johnston GM. Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combina-tions: an observational study. BMC Clin Pharmacol 2012;12:11. doi: 10. 1186/1472-6904-12-11.
4. Murray KF, Hadzic N, Wirth S, Bassett M, Kelly D. Drug-related hepatotoxicity and acute liver failure. J Pediatr Gastroenterol Nutr 2008;47:395–405. doi: 10.1097/MPG.0b013e3181709464.
5. Michna E, Duh MS, Korves C, Dahl JL. Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications. Pain Med 2010;11:369–378. doi: 10.1111/j.1526-4637.2010.00811.x.
6. Blieden M, Paramore LC, Shah D, Ben-Joseph R. A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States. Expert Rev Clin Pharmacol 2014;7:341–348. doi: 10.1586/17512433. 2014.904744.
7. Hughes B, Durran A, Langford NJ, Mutimer D. Paracetamol poisoning – impact of pack size restrictions. J Clin Pharm Ther 2003;28:307–310. doi: 10.1046/j.1365-2710.2003.00497.x.
8. McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res 2013;30: 2174–2187. doi: 10.1007/s11095-013-1007-6.
9. Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 2012;44:88–106. doi: 10. 3109/03602532.2011.602688.
10. Jaeschke H, Williams CD, Ramachandran A, Bajt ML. Acetaminophen hepa-totoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 2012;32:8–20. doi: 10.1111/j.1478-3231.2011.02501.x.
11. Yuan L, Kaplowitz N. Mechanisms of drug-induced liver injury. Clin Liver Dis 2013;17:507–518. doi: 10.1016/j.cld.2013.07.002.
12. McGill MR, Sharpe MR, Williams CD, Taha M, Curry SC, Jaeschke H. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest 2012;122:1574–1583. doi: 10.1172/JCI59755.
13. Jaeschke H, McGill MR. Cytochrome P450-derived versus mitochondrial oxidant stress in acetaminophen hepatotoxicity. Toxicol Lett 2015;235: 216–217. doi: 10.1016/j.toxlet.2015.04.002.
14. Xie Y, Ramachandran A, Breckenridge DG, Liles JT, Lebofsky M, Farhood A, et al. Inhibitor of apoptosis signal-regulating kinase 1 protects against acetami-nophen-induced liver injury. Toxicol Appl Pharmacol 2015;286:1–9. doi: 10. 1016/j.taap.2015.03.019.
15. Liu ZX, Govindarajan S, Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepato-toxicity. Gastroenterology 2004;127:1760–1774. doi: 10.1053/j.gastro. 2004.08.053.
16. Jaeschke H. Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2005;1:389–397. doi: 10.1517/17425255.1.3.389.
17. Xie Y, McGill MR, Dorko K, Kumer SC, Schmitt TM, Forster J, et al. Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. Toxicol Appl Pharmacol 2014;279:266–274. doi: 10.1016/j.taap.2014.05. 010.
18. Douglas DR, Sholar JB, Smilkstein MJ. A pharmacokinetic comparison of acetaminophen products (Tylenol Extended Relief vs regular Tylenol). Acad Emerg Med 1996;3:740–744. doi: 10.1111/j.1553-2712.1996.tb03508.x.
19. Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006;296:87–93. doi: 10.1001/jama.296.1.87.
20. Schmidt LE, Dalhoff K, Poulsen HE. Acute versus chronic alcohol consump-tion in acetaminophen-induced hepatotoxicity. Hepatology 2002;35:876– 882. doi: 10.1053/jhep.2002.32148.
21. Dart RC, Erdman AR, Olson KR, Christianson G, Manoguerra AS, Chyka PA, et al. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2006;44:1–18. doi: 10.1080/15563650500394571.
22. Waring WS, Stephen AF, Malkowska AM, Robinson OD. Acute ethanol coin-gestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose. Acad Emerg Med 2008;15:54–58. doi: 10.1111/j.1553-2712. 2007.00019.x.
23. Zhao P, Slattery JT. Effects of ethanol dose and ethanol withdrawal on rat liver mitochondrial glutathione: implication of potentiated acetaminophen toxicity in alcoholics. Drug Metab Dispos 2002;30:1413–1417. doi: 10. 1124/dmd.30.12.1413.
24. Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut 1988;29:1153–1157. doi: 10.1136/gut.29. 9.1153.
25. Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002;27:391–401. doi: 10.1046/j.1365-2710. 2002.00444.x.
26. Marzilawati AR, Ngau YY, Mahadeva S. Low rates of hepatotoxicity among Asian patients with paracetamol overdose: a review of 1024 cases. BMC Pharmacol Toxicol 2012;13:8. doi: 10.1186/2050-6511-13-8.
27. Rumack BH. Acetaminophen misconceptions. Hepatology 2004;40:10–15. doi: 10.1002/hep.20300.
28. Mennecozzi M, Landesmann B, Palosaari T, Harris G, Whelan M. Sex differences in liver toxicity-do female and male human primary hepatocytes react differently to toxicants in vitro? PLoS One 2015;10:e0122786. doi: 10. 1371/journal.pone.0122786.
29. Zenger F, Russmann S, Junker E, Wuthrich C, Bui MH, Lauterburg BH. Decreased glutathione in patients with anorexia nervosa. Risk factor for toxic liver injury? Eur J Clin Nutr 2004;58:238–243. doi: 10.1038/sj.ejcn. 1601772.
30. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994;272:1845–1850. doi: 10.1001/jama. 1994.03520230055038.
31. Organ-specific warnings: internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use-labeling for products that contain acetaminophen; guidance for industry; availability. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) 2015.
32. Krenzelok EP, Royal MA. Confusion: acetaminophen dosing changes based on NO evidence in adults. Drugs R D 2012;12:45–48. doi: 10.2165/11633010-000000000-00000.
33. Jaeschke H, Williams CD, McGill MR, Farhood A. Herbal extracts as hepato-protectants against acetaminophen hepatotoxicity. World J Gastroenterol 2010;16:2448–2450. doi: 10.3748/wjg.v16.i19.2448.
34. Jiang Y, Fan X, Wang Y. Chen P, Zeng H, Tan H, et al. Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration. Toxicol Sci 2015;143: 107–115. doi: 10.1093/toxsci/kfu216.
35. Dawson DJ, Babbs C, Warnes TW, Neary RH. Hypophosphatemia in acute liver failure. Br Med J (Clin Res Ed) 1987;295:1312–1313. doi: 10.1136/bmj.295.6609.1312.
36. Fontana RJ, Ellerbe C, Durkalski VE, Rangnekar A, Reddy RK, Stravitz T, et al. Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int 2015;35:370–380. doi: 10. 1111/liv.12632.
37. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 2002;36: 659–665. doi: 10.1053/jhep.2002.35069.
38. Ng KL, Davidson JS, Bathgate AJ. Serum phosphate is not a reliable early predictor of outcome in paracetamol induced hepatotoxicity. Liver Transpl 2004;10:158–159. doi: 10.1002/lt.20022.
39. Wang DW, Yin YM, Yao YM. Advances in the management of acute liver failure. World J Gastroenterol 2013;19:7069–7077. doi: 10.3748/wjg.v19.i41.7069.
40. Possamai LA, McPhail MJ, Quaglia A, Zingarelli V, Abeles RD, Tidswell R, et al. Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure. Crit Care Med 2013;41:2543–2550. doi: 10.1097/CCM. 0b013e31829791a2.
41. Bari K, Fontana RJ. Acetaminophen overdose: what practitioners need to know. Clinical Liver Dis 2014;4:17–21. doi: 10.1002/cld.373.
42. Rumore MM, Blaiklock RG. Influence of age-dependent pharmacokinetics and metabolism on acetaminophen hepatotoxicity. J Pharm Sci 1992;81: 203–207. doi: 10.1002/jps.2600810302.
43. Critchley JA, Nimmo GR, Gregson CA, Woolhouse NM, Prescott LF. Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 1986;22:649–657. doi: 10.1111/j.1365-2125.1986.tb02953.x.
44. Ueshima Y, Tsutsumi M, Takase S, Matsuda Y, Kawahara H. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes. Alcohol Clin Exp Res 1996;20:25A–28A. doi: 10.1111/j.1530-0277.1996. tb01722.x.
45. Zhao L, Pickering G. Paracetamol metabolism and related genetic differences. Drug Metab Rev 2011;43:41–52. doi: 10.3109/03602532.2010.527984.
46. Wilkes JM, Clark LE, Herrera JL. Acetaminophen overdose in pregnancy. South Med J 2005;98:1118–1122. doi: 10.1097/01.smj.0000184792.15407.51.
47. Thornton SL, Minns AB. Unintentional chronic acetaminophen poisoning during pregnancy resulting in liver transplantation. J Med Toxicol 2012;8: 176–178. doi: 10.1007/s13181-012-0218-2.
48. Mazer M, Perrone J. Acetaminophen-inducted nephrotoxicity: pathophysiol-ogy, clinical manifestations, and management. J Med Toxicol 2008;4:2–6. doi: 10.1007/BF03160941.
49. Caldarola V, Hassett JM, Hall AH, Bronstein AB, Kulig KW, Rumack BH. Hem-orrhagic pancreatitis associated with acetaminophen overdose. Am J Gastroenterol 1986;81:579–582.
50. Harrison PM, O’Grady JG, Keays RT, Alexander GJ, Williams R. Serial pro-thrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990;301:964–966. doi: 10.1136/bmj.301.6758.964.
51. Bailey B, Amre DK, Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003;31:299–305. doi: 10.1097/00003246-200301000-00048.
52. Cholongitas E, Theocharidou E, Vasianopoulou P, Betrosian A, Shaw S, Patch D, et al. Comparison of the sequential organ failure assessment score with the King’s College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transpl 2012;18:405–412. doi: 10.1002/lt.23370.
53. Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 2010;31:1064–1076. doi: 10.1111/j.1365-2036.2010.04279.x.
54. Rumack BH. Acetaminiphen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol 2002;40:3–20. doi: 10.1081/CLT-120002882.
55. Buehler MC, Curry SC. False positive acetaminophen levels associated with hyperbilirubinemia. Clin Toxicol (Phila) 2005;43:167–170. doi: 10.1081/CLT-200057853.
56. Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med 2008; 359:285–292. doi: 10.1056/NEJMct0708278.
57. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poi-soning. Br Med J 1979;2:1097–1100. doi: 10.1136/bmj.2.6198.1097.
58. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improve-ment by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852–1857. doi: 10.1056/NEJM199106273242604.
59. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficiency of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988;319: 1557–1562. doi: 10.1056/NEJM198812153192401.
60. Kerr F, Dawson A, Whyte IM, Buckley N, Murray L, Graudins A, et al. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 2005;45:402–408. doi: 10.1016/j.annemergmed.2004.08.040.
61. de Andrade KQ, Moura FA, dos Santos JM, de Araújo OR, de Farias Santos JC, Goulart MO. Oxidative stress and inflammation in hepatic diseases: thera-peutic possibilities of N-acetylcysteine. Int J Mol Sci 2015;16:30269–30308. doi: 10.3390/ijms161226225.
62. McGovern AJ, Vitkovitsky IV, Jones DL, Mullins ME. Can AST/ALT ratio indicate recovery after acute paracetamol poisoning? Clin Toxicol (Phila) 2015;53: 164–167. doi: 10.3109/15563650.2015.1006399.
63. Xie Y, McGill MR, Cook SF, Sharpe MR, Winefield RD, Wilkins DG, et al. Time course of acetaminophen-protein adducts and acetaminophen metabolites in circulation of overdose patients and in HepaRG cells. Xenobiotica 2015;45: 921–929. doi: 10.3109/00498254.2015.1026426.
64. Woolbright BL, McGill MR, Staggs VS, Winefield RD, Gholami P, Olyaee M, et al. Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients. Toxicol Sci 2014;142:436–444. doi: 10. 1093/toxsci/kfu195.
65. McGill MR, Staggs VS, Sharpe MR, Lee WM, Jaeschke H, Acute Liver Failure Study Group. Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology 2014;60:1336–1345. doi: 10.1002/hep.27265.
66. McGill MR, Jaeschke H. Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. Expert Opin Drug Metab Toxicol 2014;10:1005–1017. doi: 10.1517/17425255.2014.920823.
67. Thulin P, Nordahl G, Gry M, Yimer G, Aklillu E, Makonnen E, et al. Keratin-18 and microRNA-122 compliment alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts. Liver Int 2014;34:367–378. doi: 10.1111/liv.12322.
68. Yang X, Salminen WF, Shi Q, Greenhaw J, Gill PS, Bhattacharyya S, et al. Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children. Toxicol Appl Pharmacol 2015;284:180–187. doi: 10.1016/j.taap. 2015.02.013.
69. Antoine DJ, Sabbisetti VS, Francis B, Jorgensen AL, Craig DG, Simpson KJ, et al. Circulating kidney injury molecule 1 predicts prognosis and poor outcome in patients with acetaminophen-induced liver injury. Hepatology 2015;62:591–599. doi: 10.1002/hep.27857.
70. Underhill TJ, Greene MK, Dove AF. A comparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose. Arch Emerg Med 1990;7:148–154. doi: 10.1136/emj.7.3.148.
71. Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009;43:342–349. doi: 10.1097/MCG.0b013e31818a3854.
72. Buckley N, Eddleston M. Paracetamol (acetaminophen) poisoning. BMJ Clin Evid 2007;2007.
73. Reddy KR, Schilsky ML, Stravitz R, Ellerbe C, Durkalski V, Fontana RJ, et al. Liver transplantation for acute liver failure: results from the NIH Acute Liver Failure Study Group. Hepatology 2012;56:246A–247A.
74. Kaplowitz N, Win S, Than TA, Liu ZX, Dara L. Targeting signal transduction pathways which regulate necrosis in acetaminophen hepatotoxicity. J Hepatol 2015;63:5–7. doi: 10.1016/j.jhep.2015.02.050.
75. Noh JR, Kim YH, Hwang JH, Choi DH, Kim KS, Oh WK, et al. Sulforaphane protects against acetaminophen-induced hepatotoxicity. Food Chem Toxicol 2015;80:193–200. doi: 10.1016/j.fct.2015.03.020.
76. Zhang J, Song S, Pang Q, Zhang R, Zhou L, Liu S, et al. Serotonin deficiency exacerbates acetaminophen-induced liver toxicity in mice. Sci Rep 2015;5: 8098. doi: 10.1038/srep08098.
77. Bliebel W, Kim S, D’Silva K, Lemmer ER. Drug-induced liver injury: review article. Dig Dis Sci 2007;52:2463–2471. doi: 10.1007/s10620-006-9472-y.